Komori
Medical Ikkou Group (3353) · InitiativeAdvanced

Introducing a restricted stock compensation plan

First written in FY2021. 3 of 4 entries say "Advanced", first in FY2023. Latest entry: FY2026.

4entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2021AdvancedFY2023 – FY20262021: 120212022: 020222023: 120232024: 020242025: 120252026: 12026
Same theme, other companies
Medium- to Long-Term Incentives Through Equity Compensation Plans for Directors and EmployeesA theme 669 companies write about · 0 as a headwind · 692 as a tailwind

105 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 192 companies compared. The sentences above are computed from all 192.Comparing 200 of the theme's 692 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「Other (disposal of treasury shares as restricted stock compensation) 4,200 7,265」

    Under the restricted stock compensation plan, the company disposed of 4,200 treasury shares during the fiscal year. This was an increase from 3,600 shares in the previous fiscal year.
  2. FY2025AdvancedAnnual report

    「Other (disposal of treasury shares as restricted stock compensation) 3,600 6,209」

    Under the restricted stock compensation plan, the company disposed of 3,600 treasury shares during the fiscal year.
  3. FY2023AdvancedAnnual report

    「Other (disposal of treasury shares as restricted stock compensation)　1,000　1,724」

    Under the existing restricted stock compensation plan, the company disposed of 1,000 treasury shares during the fiscal year. It also recorded share-based compensation of ¥3,225 thousand for directors, ¥879 thousand for Audit & Supervisory Board members and ¥878 thousand for outside officers.
  4. FY2021First statedAnnual report

    「The company resolved to introduce a restricted stock compensation plan to provide incentives for the sustained enhancement of corporate value and promote greater sharing of value with shareholders. Separately from the existing compensation limits, it also resolved that the aggregate amount of monetary compensation to be paid for the allocation of restricted stock would be capped at ¥50,000 thousand per year for directors and ¥10,000 thousand per year for Audit & Supervisory Board members.」

    Pursuant to a resolution at the Annual General Meeting of Shareholders held on 27 May 2020, the company introduced a restricted stock compensation plan aimed at enhancing corporate value and sharing value with shareholders.
Moved together

"Expanding Business Scale and Enhancing Earnings Power" moved the same way as this thread, in the same document, in 2 of its 4 moves.

22222★12345
  1. ★This thread
  2. 1Expanding Business Scale and Enhancing Earnings Power2×
  3. 2Sales Activities of Generic Pharmaceutical Wholesalers and Expansion of Sales Areas through Subsidiarization2×
  4. 3Restructuring the Group through M&A and Subsidiary Mergers2×
  5. 4Payment of Year-End Dividend2×
  6. 5Expansion of the dispensing pharmacy network through the acquisition of pharmacy locations2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Medical Ikkou Group yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Introducing a restricted stock compensation plan | Medical Ikkou Group Co.,Ltd. (3353) | Komori